An observational study in Down Syndrome, sponsored by Université de Reims Champagne-Ardenne. Status unknown at 1 site in France. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-11-07.
Sponsored by Université de Reims Champagne-Ardenne · Observational
Gynaecological check-ups for women are recommended in France. However, some groups of the population are affected by a lack or absence of medical surveillance.
In France, there are one million people with an intellectual disability, including 50,000 with Down syndrome.
Although this disability causes numerous physical and psychological deficits, no gynaecological consequences have yet been demonstrated.
Regular gynaecological check-ups are therefore necessary, according to French recommendations.
However, several studies have shown that women with mental illness receive less or no gynaecological care.
The aim is to describe the gynaecological follow-up of women with Down syndrom in France.
438 studies on the registry are indexed under Down Syndrome; 100 are open to participants now.
This study's planned enrollment of 100 is below the median of 141 across 145 observational studies indexed under Down Syndrome.
Browse Down Syndrome studies →Université de Reims Champagne-Ardenne is the lead sponsor of 64 studies on the registry; 21 are open to participants now.
Counted across the registry records on this site, refreshed daily.
women with Down syndrome, aged 18 to 30, whether or not they are being followed up in medical facilities in France.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
women aged 18 to 30 with Down syndrome, whether or not they were receiving medical care, who agreed to take part in the study.
Other: Data collection
Data collection
Gynaecological follow-up
Presence or not of gynaecological follow-up
Time frame: Day 0
Plan to share: Undecided
No publications or documents are linked to this record.
This study is status unknown, as verified in Oct 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Université de Reims Champagne-Ardenne